These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 23740717)

  • 1. Implications of HIV drug resistance on first- and second-line therapies in resource-limited settings: report from a workshop organized by the Collaborative HIV and Anti-HIV Drug Resistance Network.
    Pillay D; Albert J; Bertagnolio S; Boucher C; Brun-Vezinet F; Clotet B; Giaquinto C; Perno CF
    Antivir Ther; 2013; 18(6):831-6. PubMed ID: 23740717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minority HIV-1 drug-resistant mutations and prevention of mother-to-child transmission: perspectives for resource-limited countries.
    Samuel R; Paredes R; Parboosing R; Moodley P; Gordon M
    AIDS Rev; 2014; 16(4):187-98. PubMed ID: 25300623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiretroviral therapy for prevention of mother-to-child HIV transmission : focus on single-dose nevirapine.
    Giaquinto C; Rampon O; De Rossi A
    Clin Drug Investig; 2006; 26(11):611-27. PubMed ID: 17163296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of vertical transmission of HIV-1 in resource-limited settings.
    Coutsoudis A; Kwaan L; Thomson M
    Expert Rev Anti Infect Ther; 2010 Oct; 8(10):1163-75. PubMed ID: 20954881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The requirement for surveillance of HIV drug resistance within antiretroviral rollout in the developing world.
    Bennett DE
    Curr Opin Infect Dis; 2006 Dec; 19(6):607-14. PubMed ID: 17075338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiretroviral (ARV) drug resistance in the developing world.
    Shekelle P; Maglione M; Geotz MB; Wagner G; Wang Z; Hilton L; Carter J; Chen S; Tringle C; Mojica W; Newberry S
    Evid Rep Technol Assess (Full Rep); 2007 Sep; (156):1-74. PubMed ID: 18088163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring antiretroviral therapy in resource-limited settings: balancing clinical care, technology, and human resources.
    Hosseinipour MC; Schechter M
    Curr HIV/AIDS Rep; 2010 Aug; 7(3):168-74. PubMed ID: 20499290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV drug resistance in mothers and infants following use of antiretrovirals to prevent mother-to-child transmission.
    Ton Q; Frenkel L
    Curr HIV Res; 2013 Mar; 11(2):126-36. PubMed ID: 23432488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Optimizing resources to reduce costs to determine HIV viral load in limited resources settings].
    Girón-Callejas A; Mendizabal-Burastero R; Yax E; Martínez A; Mejía-Villatoro C
    Biomedica; 2017 Dec; 37(4):460-465. PubMed ID: 29373766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mother-to-child transmission of HIV infection and its prevention.
    Thorne C; Newell ML
    Curr HIV Res; 2003 Oct; 1(4):447-62. PubMed ID: 15049430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence of HIV drug resistance during first- and second-line antiretroviral therapy in resource-limited settings.
    Hosseinipour MC; Gupta RK; Van Zyl G; Eron JJ; Nachega JB
    J Infect Dis; 2013 Jun; 207 Suppl 2(Suppl 2):S49-56. PubMed ID: 23687289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Impact of HIV Drug Resistance on the Selection of First- and Second-Line ART in Resource-Limited Settings.
    Bertagnolio S; Perno CF; Vella S; Pillay D
    J Infect Dis; 2013 Jun; 207 Suppl 2():S45-8. PubMed ID: 23687288
    [No Abstract]   [Full Text] [Related]  

  • 13. Antiretroviral prophylaxis of perinatal HIV-1 transmission and the potential impact of antiretroviral resistance.
    Nolan M; Fowler MG; Mofenson LM
    J Acquir Immune Defic Syndr; 2002 Jun; 30(2):216-29. PubMed ID: 12045685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 drug resistance and mother-to-child transmission.
    Morris L; Pillay C; Gray G; McIntyre J
    SADJ; 2001 Dec; 56(12):614-6. PubMed ID: 11887450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV drug resistance in low-income and middle-income countries.
    Hamers RL; Rinke de Wit TF; Holmes CB
    Lancet HIV; 2018 Oct; 5(10):e588-e596. PubMed ID: 30193863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiretroviral treatment sequencing strategies to overcome HIV type 1 drug resistance in adolescents and adults in low-middle-income countries.
    De Luca A; Hamers RL; Schapiro JM
    J Infect Dis; 2013 Jun; 207 Suppl 2():S63-9. PubMed ID: 23687291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [HIV treatment by ARV in resource-poor francophone countries].
    Lepère P; Milleliri JM
    Med Sante Trop; 2015; 25(3):237-44. PubMed ID: 26446740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in the prevention of mother-to-child transmission of HIV-1 infection in resource-limited settings.
    Ekouevi DK; Tonwe-Gold B; Dabis F
    AIDS Read; 2005 Sep; 15(9):479-80, 487-93. PubMed ID: 16170877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. International recommendations on antiretroviral drugs for treatment of HIV-infected women and prevention of mother-to-child HIV transmission in resource-limited settings: 2006 update.
    Dao H; Mofenson LM; Ekpini R; Gilks CF; Barnhart M; Bolu O; Shaffer N
    Am J Obstet Gynecol; 2007 Sep; 197(3 Suppl):S42-55. PubMed ID: 17825650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The urgent need for feasibility studies of antiretroviral treatment in HIV-infected individuals in resource-limited settings.
    van der Groen G
    AIDS; 2001 Nov; 15(17):2342-4. PubMed ID: 11698717
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.